Michael Tam

Michael Tam is a Senior Lecturer in the Discipline of General Practice, the University of Sydney. There, he is the academic lead in running courses for health administrators and GPs from (the People's Republic of) China. He is also a Staff Specialist at the academic General Practice Unit, South Western Sydney Local Health District and Ingham Institute. The Unit provides family medicine services to the diverse communities of South Western Sydney, medical education, research, and health services development, especially in integrated care. Michael's clinical interest is in comorbid substance use disorder and mental health disorders. His research interests are risky drinking detection in primary care, integrated care, and medical education.

Most commented posts

  1. Glucosamine and/or chondroitin for osteoarthritis — 2 comments
  2. Incidence and progression of thyroid dysfunction in elderly — 2 comments
  3. Daily aspirin on long-term risk of death due to cancer — 1 comment
  4. Is glucosamine effective for osteoarthritis pain? — 1 comment
  5. Zinc for the common cold — 1 comment

Author's posts

Jan 19

Reboxetine for acute treatment of major depression

Eyding D, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and SSRI. BMJ 2010;341:c4737
Reboxetine is no more effective than placebo for major depressive disorder.

Jan 14

Placebos for irritable bowel syndrome

Kaptchuk TJ, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS ONE 2010; 5(12): e15591
The positive results widely reported for placebo pills in consenting patients with irritable bowel syndrome are likely invalid due to serious methodological limitations in the study.

Jan 12

Severe hypoglycemia and risk of vascular events and death

Zoungas S, et al. Severe hypoglycemia and risk of vascular events and death. N Engl J Med 2010;363:1410-8
Severe hypoglycaemia is strongly associated with increased risk of vascular events and death (~ 350% ↑ risk).

Jan 05

Subclinical hypothyroidism and coronary heart disease

Rondondi N, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374.
Subclinical hypothyroidism (elevated TSH with normal thyroxine levels) is associated with increased risk of coronary heart disease (CHD) events and mortality.